Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PIPELINE-RSV International Trial. Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)- RSV International Immunisation Adaptive Platform Trial.

NCT07041190 is registered in ClinicalTrials.gov with PENTA Foundation as lead sponsor.

NCT NCT07041190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07041190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PIPELINE-RSV International Trial. Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)- RSV International Immunisation Adaptive Platform Trial.
Lead sponsor
PENTA Foundation
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
December 31, 2028
Enrollment
1,500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rsv immunization